Inovalon Holdings, Inc. INOV

Inovalon Holdings, Inc. Book Value 2011-2026 | INOV

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value Inovalon Holdings, Inc.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
26.4 M	29.6 M	22.9 M	27.1 M	27.2 M	30.2 M	34.7 M	36.3 M	36.3 M	48.9 M	40.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48.9 M	22.9 M	32.7 M

Book Value of other stocks in the Health information services industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
American Well Corporation AMWL	248 M	$ 5.52	1.1 %	$ 88.6 M	USA
Accolade ACCD	391 M	-	0.29 %	$ 206 M	USA
Cerner Corporation CERN	3.68 B	-	-	$ 27.9 B	USA
Covetrus CVET	1.53 B	-	-	$ 2.94 B	USA
Computer Programs and Systems CPSI	187 M	-	4.4 %	$ 133 M	USA
Castlight Health, Inc. CSLT	7.25 B	-	-7.28 %	$ 227 M	USA
HMS Holdings Corp. HMSY	715 M	-	-	$ 3.29 B	USA
iCAD ICAD	28.7 M	-	-	$ 102 M	USA
HealthStream HSTM	511 M	$ 21.86	-0.86 %	$ 664 M	USA
Akerna Corp. KERN	-7.01 M	-	-	$ 161 M	USA
Evolent Health EVH	859 M	$ 3.35	-5.77 %	$ 314 M	USA
HealthEquity HQY	2.04 B	$ 80.0	-1.42 %	$ 6.85 B	USA
Allscripts Healthcare Solutions MDRX	1.41 B	-	-10.39 %	$ 886 M	USA
Change Healthcare CHNG	3.28 B	-	-	$ 9.03 B	USA
So-Young International SY	1.96 B	$ 2.91	1.04 %	$ 231 M	China
MTBC MTBC	49.8 M	-	-0.58 %	$ 51.7 M	USA
Omnicell OMCL	1.24 B	$ 41.91	0.92 %	$ 1.93 B	USA
1Life Healthcare ONEM	1.73 B	-	-	$ 3.37 B	USA
GoodRx Holdings GDRX	725 M	$ 2.28	4.59 %	$ 879 M	USA
Health Catalyst HCAT	365 M	$ 1.92	-1.79 %	$ 116 M	USA
R1 RCM RCM	347 M	-	-	$ 3.81 B	USA
Progyny PGNY	422 M	$ 17.61	-1.01 %	$ 1.51 B	USA
Premier PINC	1.53 B	-	-	$ 2.33 B	USA
NantHealth NH	-225 M	-	-46.64 %	$ 10.4 M	USA
OptimizeRx Corporation OPRX	127 M	$ 7.66	-2.67 %	$ 131 M	USA
NextGen Healthcare NXGN	432 M	-	-	$ 1.6 B	USA
Phreesia PHR	251 M	$ 12.11	-4.12 %	$ 661 M	USA
Schrödinger SDGR	364 M	$ 12.96	-1.26 %	$ 952 M	USA
Teladoc Health TDOC	1.39 B	$ 5.11	-0.49 %	$ 900 M	USA
Zhongchao ZCMD	24.2 M	$ 1.71	2.4 %	$ 8.9 M	China
Signify Health SGFY	821 M	-	-0.02 %	$ 7.21 B	USA
Streamline Health Solutions STRM	12.3 M	-	-	$ 21.4 M	USA
10x Genomics TXG	741 M	$ 21.85	-2.32 %	$ 2.56 B	USA
Tabula Rasa HealthCare TRHC	-57 M	-	-	$ 255 M	USA
Veeva Systems VEEV	4.64 B	$ 195.36	3.65 %	$ 31.4 B	USA
SCWorx Corp. WORX	4.49 M	$ 0.13	-4.02 %	$ 190 K	USA